Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
90 studies found for:    Open Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Adverse Drug Events" OR "Adverse Drug Reactions" OR "Drug Related Side Effects" (90 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
Conditions: Adverse Drug Events;   Adverse Drug Reactions
Intervention: Drug: Qingkailing Injection
2 Not yet recruiting Information Systems-enabled Outreach Program for Adverse Drug Events
Condition: Adverse Drug Events
Intervention: Other: ISTOP-ADE
3 Recruiting National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Condition: Adverse Drug Reaction (ADR)
Intervention:
4 Recruiting Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Conditions: Safety Surveillance;   Adverse Drug Events;   Adverse Drug Reactions;   Severe Adverse Events;   Severe Adverse Reactions
Intervention: Drug: Compound Kuh-seng Injection
5 Recruiting YouScript IMPACT Registry
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention:
6 Recruiting Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons
Condition: Adverse Drug Reactions
Intervention:
7 Not yet recruiting Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Condition: Adverse Drug Events
Interventions: Other: Pharmacist obtains admission medication history;   Other: Pharmacy technician obtains admission medication history
8 Recruiting Multi-Center Medication Reconciliation Quality Improvement Study
Conditions: Adverse Drug Events;   Medication Administered in Error
Intervention: Other: Mentored medication reconciliation quality improvement
9 Recruiting Using Novel Canadian Resources to Improve Medication Reconciliation at Discharge
Conditions: Medication Reconciliation;   Adverse Drug Events
Intervention: Other: Electronic Medication Reconciliation
10 Recruiting the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
Conditions: Adverse Drug Reaction;   Medication Administered in Error
Intervention: Other: integrated medicines management
11 Recruiting Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Conditions: Adverse Drug Reaction;   Cinepazide;   Stroke
Intervention:
12 Recruiting The Drug Induced Renal Injury Consortium
Conditions: Acute Kidney Injury;   Adverse Drug Reaction;   Acute Kidney Failure;   Kidney Failure;   Kidney Disease
Intervention:
13 Recruiting Diagnosing Adverse Drug Reactions Registry
Condition: Genetics of Drug Metabolism
Intervention:
14 Recruiting Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study
Condition: Adverse Drug Reaction
Intervention:
15 Not yet recruiting A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Condition: Adverse Drug Reaction
Intervention: Device: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
16 Not yet recruiting Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
Conditions: Adverse Drug Reaction;   Drug Allergy
Intervention:
17 Recruiting Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients
Conditions: Adverse Drug Reaction;   Anxiety Disorders and Symptoms
Intervention:
18 Unknown  Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
19 Unknown  ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug Effects
Condition: Diabetes Mellitus Type 2
Intervention:
20 Unknown  Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Conditions: Depression;   Continuous Antidepressant Abuse;   Adverse Reaction to Drug
Intervention: Drug: Escitalopram

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years